Ocular Therapeutix
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Purchase
SAWHNEY AMARPREET director, officer: Chairman of ..
Common Stock 15,000 $16.64 $249,600
Sale
VERSANT VENTURE CAPITAL III, L.P. 10 percent owner
Common Stock 320,000 $22 $7,040,000
Sale
WARDEN CHARLES M director
Common Stock 320,000 $22 $7,040,000
Sale
SVLSF IV, LLC 10 percent owner
Common Stock 746,000 $22 $16,412,000
Sale
WARDEN CHARLES M director
Common Stock 427,000 $22 $9,394,000
Sale
VERSANT VENTURE CAPITAL III, L.P. 10 percent owner
Common Stock 427,000 $22 $9,394,000
Option
SAWHNEY AMARPREET director, officer: Chairman of ..
Common Stock 51,491 $1.35 $69,513
Option
SAWHNEY AMARPREET director, officer: Chairman of ..
Stock Option (Right to Buy) 51,491 $1.35 $69,513
Option
LINDSTROM RICHARD L MD director
Common Stock 24,620 $0.55 $13,541
Option
LINDSTROM RICHARD L MD director
Stock Option (right to buy) 18,939 $0.14 $2,651
Sale
POLARIS VENTURE MANAGEMENT CO. V, L.L.C. 10 percent owner
Common Stock 500,000 $29.5 $14,750,000
Purchase
SVLSF IV, LLC 10 percent owner
Common Stock 476,920 $13 $6,199,960
Purchase
SAWHNEY AMARPREET director, officer: Chairman of ..
Common Stock 76,922 $13 $999,986
Purchase
ANKERUD ERIC officer: See Remarks
Common Stock 1,000 N/A N/A
Purchase
CHV II, L.P. 10 percent owner
Common Stock 153,846 $13 $1,999,998
Purchase
SVLSF IV, LLC 10 percent owner
Common Stock 476,920 $13 $6,199,960

Showing 100 to 116 of 116 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.